2'-o-modified rna
AssigneesThe University of Tokyo, Chiralgen, Ltd.
InventorsMamoru Shimizu, Takeshi Wada, Kouichiro Arai
Life of this patent
Estimating the term…
Loading patent…
AssigneesThe University of Tokyo, Chiralgen, Ltd.
InventorsMamoru Shimizu, Takeshi Wada, Kouichiro Arai
Estimating the term…
[Problem] To provide a 2′-modified ribonucleoside or the like which has a high duplex-forming ability. [Solution] The present invention is generally based on the finding in embodiments that a modified form of a ribonucleoside or the like having an alkoxymethyl protective group can be imparted with a high duplex-forming ability by introducing, as a substituent, a halogen atom into the protective group moiety. As explained before, a modified form of RNA having an alkoxymethyl protective group has a low duplex-forming ability. A modified form of RNA having a halogen-substituted alkoxymethyl protective group, however, exhibits a high duplex-forming ability that is comparable to the duplex-forming ability of a 2′-O-methyl modified nucleic acid.
A ribonucleoside, a ribonucleotide, or a derivative thereof having a protective group at the 2′-position, wherein the protective group is represented by the following Formula (I).
A method of manufacturing a ribonucleoside, a ribonucleotide, or a derivative thereof represented by the following Formula (I) and having a protective group at the 2′-position, the method comprising:
Dependencies are inferred from the claim text.